Item 2.02. Results of Operations and Financial Condition

On March 13, 2008, SciClone Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2007. A copy of the Company's press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(a) Financial statements:
            None
(b) Pro forma financial information:
            None
(c) Shell company transactions:
            None
(d) Exhibits

            99.1       Press Release of SciClone Pharmaceuticals, Inc. dated March 13, 2008

SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: March 13, 2008
 SCICLONE PHARMACEUTICALS, INC.

By:  /s/ Richard A. Waldron                    
     Richard A. Waldron
     Executive Vice President and Chief Financial Officer

Exhibit Index
Exhibit No. Description
99.1 Press Release of SciClone Pharmaceuticals, Inc. dated March 13, 2008